← All organizations
Highest phase reached
Phase 3
First clinical trial
May 9, 2009Last known activity
Sep 27, 2019
Timeline
2000s
- Jun 1, 2000
ClinAssess GmbH— Founded
Drugs by trial phase (33 distinct, 22 trials)
Phase 3 (12 own, 0 via acquisition)
Phase 2 (21 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Brain Neoplasms
- Bronchiolitis
- Bronchiolitis Obliterans
- Carcinoma
- Carcinoma, Ovarian Epithelial
- Colorectal Neoplasms
- Disease Progression
- Graft vs Host Disease
- Hypersensitivity
- Lung Neoplasms
- Lymphoma
- Lymphoma, Mantle-Cell
- Melanoma
- Multiple Myeloma
- Myelodysplastic Syndromes
- Neoplasm Metastasis
- Neoplasms, Plasma Cell
- Neoplasms, Second Primary
- Ovarian Neoplasms
- Pancreatic Neoplasms
- Preleukemia
- Syndrome
- Uveal Neoplasms
Recent trials (22)
- NCT05217069CollaboratorPhase 2Sep 27, 2019
- NCT04034173CollaboratorPhase 2Aug 1, 2019
- NCT03948035CollaboratorPhase 3Aug 28, 2018
- NCT02564146CollaboratorPhase 2Dec 1, 2016
- NCT02166658CollaboratorPhase 2Aug 1, 2015
- NCT02047513CollaboratorPhase 2Apr 1, 2015
- NCT02125136CollaboratorPhase 2Nov 1, 2014
- NCT01991873CollaboratorPhase 2Apr 1, 2014
- NCT01639261CollaboratorPhase 2Jul 1, 2012
- NCT01614301CollaboratorPhase 1/Phase 2May 1, 2012
- NCT01685814CollaboratorPhase 3May 1, 2012
- NCT01509560CollaboratorPhase 2Nov 1, 2011
- NCT01388621CollaboratorPhase 2Oct 1, 2011
- NCT01418742CollaboratorPhase 2Aug 1, 2011
- NCT01377025CollaboratorPhase 2Jun 1, 2011
Details
- Founded
- Leverkusen, DE Jun 1, 2000
- Last known activity
- Sep 27, 2019
Notes
CRO